Understanding the Impact of Nitrogen Availability: A Limiting Factor for Enhancing Fucoxanthin Productivity in Microalgae Cultivation
Marine Drugs · 2024
DOI: 10.3390/md22020093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von To Quyen Truong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bio-Medical Science & Technology, Korea Institute of Science and Technology (KIST) School, University of Science and Technology, Seoul 02…. Hauptthemen laut MEDLINE: Microalgae, Diatoms, Xanthophylls. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the intramural grant from the Korea Institute of Science and Technology (KIST), the Korea Institute of Science and Technology (KIST), Republic of Korea.
Abstract (Originalsprache)
This study aimed to investigate the regulation of fucoxanthin (FX) biosynthesis under various nitrogen conditions to optimize FX productivity in Phaeodactylum tricornutum. Apart from light, nitrogen availability significantly affects the FX production of microalgae; however, the underlying mechanism remains unclear. In batch culture, P. tricornutum was cultivated with normal (NN, 0.882 mM sodium nitrate), limited (LN, 0.22 mM), and high (HN, 8.82 mM) initial nitrogen concentrations in f/2 medium. Microalgal growth and photosynthetic pigment production were examined, and day 5 samples were subjected to fucoxanthin–chlorophyll a/c-binding protein (FCP) proteomic and transcriptomic analyses. The result demonstrated that HN promoted FX productivity by extending the exponential growth phase for higher biomass and FX accumulation stage (P1), showing a continuous increase in FX accumulation on day 6. Augmented FX biosynthesis via the upregulation of carotenogenesis could be primarily attributed to enhanced FCP formation in the thylakoid membrane. Key proteins, such as LHC3/4, LHCF8, LHCF5, and LHCF10, and key genes, such as PtPSY, PtPDS, and PtVDE, were upregulated under nitrogen repletion. Finally, the combination of low light and HN prolonged the P1 stage to day 10, resulting in maximal FX productivity to 9.82 ± 0.56 mg/L/day, demonstrating an effective strategy for enhancing FX production in microalgae cultivation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Bio-Medical Science & Technology, Korea Institute of Science and Technology (KIST) School, University of Science and Technology, Seoul 02792, Republic of Korea.
- Smart Farm Research Center, KIST Gangneung Institute of Natural Products, Gangneung 25451, Republic of Korea.
- Natural Product Informatics Research Center, KIST Gangneung Institute of Natural Products, Gangneung 25451, Republic of Korea.
ORCID-Profile: To Quyen Truong, Yun Ji Park, Jessica Winarto, Yeong Bin Choi, Dae-Geun Song, Sang Min Kim
Förderung
- the intramural grant from the Korea Institute of Science and Technology (KIST)
- the Korea Institute of Science and Technology (KIST), Republic of Korea
Zitieren
APA
Truong, T. Q., Park, Y. J., Winarto, J., Huynh, P. K., Moon, J., Choi, Y. B., Song, D. G., Koo, S. Y., & Kim, S. M. (2024). Understanding the Impact of Nitrogen Availability: A Limiting Factor for Enhancing Fucoxanthin Productivity in Microalgae Cultivation. Marine Drugs. https://doi.org/10.3390/md22020093
Vancouver
Truong TQ, Park YJ, Winarto J, Huynh PK, Moon J, Choi YB, et al. Understanding the Impact of Nitrogen Availability: A Limiting Factor for Enhancing Fucoxanthin Productivity in Microalgae Cultivation. Marine Drugs. 2024. doi:10.3390/md22020093
BibTeX
@article{Truong2024,
author = {Truong, To Quyen and Park, Yun Ji and Winarto, Jessica and Huynh, Phuong Kim and Moon, Jinyoung and Choi, Yeong Bin and Song, Dae-Geun and Koo, Song Yi and Kim, Sang Min},
title = {Understanding the Impact of Nitrogen Availability: A Limiting Factor for Enhancing Fucoxanthin Productivity in Microalgae Cultivation},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22020093}
}
EUVIMED